BioAtla Inc (NASDAQ: BCAB) is 14.68% higher on its value in year-to-date trading and has touched a low of $0.57 and a high of $4.02 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BCAB stock was last observed hovering at around $0.61 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $0.68, the stock is -37.06% and -55.75% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.44 million and changing 10.42% at the moment leaves the stock -64.81% off its SMA200. BCAB registered -72.33% loss for a year compared to 6-month gain of -48.64%. The firm has a 50-day simple moving average (SMA 50) of $1.5323 and a 200-day simple moving average (SMA200) of $1.92675.
The stock witnessed a -57.36% loss in the last 1 month and extending the period to 3 months gives it a -71.15%, and is 5.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.93% over the week and 11.59% over the month.
BioAtla Inc (BCAB) has around 65 employees, a market worth around $43.44M and $11.00M in sales. Profit margin for the company is -743.79%. Distance from 52-week low is 18.95% and -83.13% from its 52-week high. The company has generated returns on investments over the last 12 months (-356.22%).
The EPS is expected to grow by 40.93% this year.
BioAtla Inc (BCAB) Top Institutional Holders
80.0 institutions hold shares in BioAtla Inc (BCAB), with institutional investors hold 39.12% of the company’s shares. The shares outstanding are 48.35M, and float is at 46.83M with Short Float at 8.43%. Institutions hold 35.61% of the Float.
The top institutional shareholder in the company is SOLEUS CAPITAL MANAGEMENT, L.P. with over 3.9 million shares valued at $5.34 million. The investor’s holdings represent 8.113% of the BCAB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.89 million shares valued at $2.58 million to account for 3.9205 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 1.85 million shares representing 3.8571% and valued at over $2.54 million, while MILLENNIUM MANAGEMENT LLC holds 3.4297 of the shares totaling 1.65 million with a market value of $2.26 million.
BioAtla Inc (BCAB) Insider Activity
#####
